0

Close
 
Upcoming Allied Market Research
2023
Neurosurgery Devices Market

Neurosurgery Devices Market

by Product (Neurosurgery Devices, External Neurosurgery Devices, Neuroendoscopy Devices), by Application (Spinal Cord Stimulation, Deep Brain Stimulation, Neuro-endoscopy) and by End User (Hospitals, Ambulatory Surgery Center, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032

LS : Medical Devices & Supplies
Report Code: A06255
Nov 2023 | Pages: NA
Tables: NA
Charts: NA

  • Formats*:

  • pdf

    Single User License, Five User
    License & Enterprise User License

  • xls

    Data Pack Excel License

  • ppt

    It comes with the additional cost
    of $2500.00 contact sales.
 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Neurosurgery Devices Market

Request Now !

Neurosurgery devicesare devices that help in prevention, treatment, and diagnosis of conditions and disorders associated with nervous system mainly the brain, spinal cord, peripheral nerves, and extra-cranial cerebrovascular system. The neurological conditions include dementia, headache disorders, neuro-infections, and multiple sclerosis, traumatic brain injuries, pain associated with neurological disorders, neurological disorders associated with malnutrition, stroke, epilepsy and Parkinson’s disease.These disorders are fatal and cannot be cured by therapeutics. Some of the neurosurgery devices are neuro-endoscopes, Stereotactic Systems, Catheters, Pacemakers, Single- and Dual-Chamber Defibrillators, Implantable Cardioverter Defibrillator among others that are used in a variety of neurosurgical procedures. 

As per the data published by Bright Focus Foundation, approximately 50 million people are expected to be living with Alzheimer's disease or dementias. If breakthroughs are not identified, rates could surpass 152 million by 2050.Furthermore, as per Parkinson's Foundation, approximately 10 million people across the world are living with PD. 60,000 Americans are diagnosed with Parkinson's each year. The Parkinson’s Foundation Prevalence Project estimated that approximately 930,000 people in the U.S. will be living with Parkinson's by the year 2020. The incidence rate is predicted to rise to 1.2 million by 2030. This rise in incidences of neurological conditions is expected to create newer opportunities for the growth of the neurosurgery devices market. 

Rise in incidences and prevalence of neurological conditions within the population and the advantage of neurosurgery over other conventional surgeries are expected to boost the growth of the neurosurgery devices market across the globe. However, higher costs involved in neuro endoscopy equipment and procedures along with lack of trained professionals is anticipated to hamper the market growth. On the contrary, recent advances in neurological surgeries such as 3-Dimension Reconstruction for brain tumor surgery,X-Knife Radiosurgery for brain lesions, MRI for brain tumors, and surgery under local anesthesia for brain tumors are anticipated to provide lucrative opportunities for the growth of the neurosurgery devices market across the globe. 

The neurosurgery devices market is classified on the basis ofproduct, application, and region. Based on product, the market is divided into neurosurgery devices, external neurosurgery devices,and neuro-endoscopy devices. Based on neurosurgerydevices, the market is classified into internal neurosurgery devices, spinal cord stimulation devices, deep brain stimulation devices, and other internal neurosurgery devices. Based on application, the market is classifiedinto spinal cord stimulation, deep brain stimulation, and neuro-endoscopy. Furthermore, thespinal cord stimulation segment is further sub-segmented into chronic pain, failed back surgery syndrome, and ischemia. Whereasdeep brain stimulation segment is further sub-segmented intoParkinson’s disease, tremor, depression, and other DBS applications. Based on neuro-endoscopy, the market is classified into trans-nasal neuro-endoscopy, intraventricular neuro-endoscopy, and trans cranialneuro-endoscopy. Region wise, the market is studied across North America, Europe, Asia-Pacific, and LAMEA.

Some of the major players operating in the neurosurgery devices market includeB. Braun Melsungen, Hangzhou Hawk Optical Electronic Instruments, Medtronic, Boston Scientific Corporation, Ackermann Instrumente, Nevro Corporation, Adeor Medical, Karl Storz, Abbott, and Machida Endoscope Co., Ltd.

Key Benefits For Stakeholders

  • This report provides a detailed quantitative analysis of the current market trends and the neurosurgery devices market forecast estimations which assists to identify the prevailing opportunities. 

  • A comprehensive analysis of the factors that drive and restrain the growth of the market is provided.

  • Region-wise and country-wise market conditions are comprehensively analyzed in this report.

  • The projections in this report are made by analyzing the current neurosurgery devices market trends and future market potential in terms of value.

  • An extensive analysis of various regions provides insights that are expected to allow companies to strategically plan their business moves.

  • The key neurosurgery devices market players with in the market are profiled in this report and their strategies are analyzed thoroughly, which helpin understanding competitive outlook of neurosurgery devices market.

  • An in-depth neurosurgery devices market analysisincludes analysis of various regions and is anticipated to provide a detailed understanding of the current trends to enable stakeholders formulate region-specific plans.

 Neurosurgery Devices Market Report Highlights

Aspects Details
By Product
  • Neurosurgery Devices
  • External Neurosurgery Devices
  • Neuroendoscopy Devices
By Application
  • Spinal Cord Stimulation
  • Deep Brain Stimulation
  • Neuro-endoscopy
By End User
  • Hospitals
  • Ambulatory Surgery Center
  • Others
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (France, Germany, Italy, Spain, UK, Rest of Europe)
  • Asia-Pacific  (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific)
  • LAMEA  (Brazil, South Africa, Saudi Arabia, Rest of LAMEA)
Key Market Players Medtronic, Ackermann Instrumente, Boston Scientific Corporation, Hangzhou Hawk Optical Electronic Instruments, Nevro Corporation, Adeor Medical, Abbott, B Braun Melsungen, Machida Endoscope Co. Ltd., Karl Storz
 

  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

    • 3.6. COVID-19 Impact Analysis

  • CHAPTER 4: NEUROSURGERY DEVICES MARKET, BY PRODUCT

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Product

    • 4.2. Neurosurgery Devices

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

    • 4.3. External Neurosurgery Devices

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

    • 4.4. Neuroendoscopy Devices

      • 4.4.1. Key Market Trends, Growth Factors and Opportunities

      • 4.4.2. Market Size and Forecast, By Region

      • 4.4.3. Market Share Analysis, By Country

  • CHAPTER 5: NEUROSURGERY DEVICES MARKET, BY APPLICATION

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By Application

    • 5.2. Spinal Cord Stimulation

      • 5.2.1. Key Market Trends, Growth Factors and Opportunities

      • 5.2.2. Market Size and Forecast, By Region

      • 5.2.3. Market Share Analysis, By Country

    • 5.3. Deep Brain Stimulation

      • 5.3.1. Key Market Trends, Growth Factors and Opportunities

      • 5.3.2. Market Size and Forecast, By Region

      • 5.3.3. Market Share Analysis, By Country

    • 5.4. Neuro-endoscopy

      • 5.4.1. Key Market Trends, Growth Factors and Opportunities

      • 5.4.2. Market Size and Forecast, By Region

      • 5.4.3. Market Share Analysis, By Country

  • CHAPTER 6: NEUROSURGERY DEVICES MARKET, BY END USER

    • 6.1. Market Overview

      • 6.1.1 Market Size and Forecast, By End User

    • 6.2. Hospitals

      • 6.2.1. Key Market Trends, Growth Factors and Opportunities

      • 6.2.2. Market Size and Forecast, By Region

      • 6.2.3. Market Share Analysis, By Country

    • 6.3. Ambulatory Surgery Center

      • 6.3.1. Key Market Trends, Growth Factors and Opportunities

      • 6.3.2. Market Size and Forecast, By Region

      • 6.3.3. Market Share Analysis, By Country

    • 6.4. Others

      • 6.4.1. Key Market Trends, Growth Factors and Opportunities

      • 6.4.2. Market Size and Forecast, By Region

      • 6.4.3. Market Share Analysis, By Country

  • CHAPTER 7: NEUROSURGERY DEVICES MARKET, BY REGION

    • 7.1. Market Overview

      • 7.1.1 Market Size and Forecast, By Region

    • 7.2. North America

      • 7.2.1. Key Market Trends and Opportunities

      • 7.2.2. Market Size and Forecast, By Product

      • 7.2.3. Market Size and Forecast, By Application

      • 7.2.4. Market Size and Forecast, By End User

      • 7.2.5. Market Size and Forecast, By Country

      • 7.2.6. U.S. Neurosurgery Devices Market

        • 7.2.6.1. Market Size and Forecast, By Product
        • 7.2.6.2. Market Size and Forecast, By Application
        • 7.2.6.3. Market Size and Forecast, By End User

      • 7.2.7. Canada Neurosurgery Devices Market

        • 7.2.7.1. Market Size and Forecast, By Product
        • 7.2.7.2. Market Size and Forecast, By Application
        • 7.2.7.3. Market Size and Forecast, By End User

      • 7.2.8. Mexico Neurosurgery Devices Market

        • 7.2.8.1. Market Size and Forecast, By Product
        • 7.2.8.2. Market Size and Forecast, By Application
        • 7.2.8.3. Market Size and Forecast, By End User

    • 7.3. Europe

      • 7.3.1. Key Market Trends and Opportunities

      • 7.3.2. Market Size and Forecast, By Product

      • 7.3.3. Market Size and Forecast, By Application

      • 7.3.4. Market Size and Forecast, By End User

      • 7.3.5. Market Size and Forecast, By Country

      • 7.3.6. France Neurosurgery Devices Market

        • 7.3.6.1. Market Size and Forecast, By Product
        • 7.3.6.2. Market Size and Forecast, By Application
        • 7.3.6.3. Market Size and Forecast, By End User

      • 7.3.7. Germany Neurosurgery Devices Market

        • 7.3.7.1. Market Size and Forecast, By Product
        • 7.3.7.2. Market Size and Forecast, By Application
        • 7.3.7.3. Market Size and Forecast, By End User

      • 7.3.8. Italy Neurosurgery Devices Market

        • 7.3.8.1. Market Size and Forecast, By Product
        • 7.3.8.2. Market Size and Forecast, By Application
        • 7.3.8.3. Market Size and Forecast, By End User

      • 7.3.9. Spain Neurosurgery Devices Market

        • 7.3.9.1. Market Size and Forecast, By Product
        • 7.3.9.2. Market Size and Forecast, By Application
        • 7.3.9.3. Market Size and Forecast, By End User

      • 7.3.10. UK Neurosurgery Devices Market

        • 7.3.10.1. Market Size and Forecast, By Product
        • 7.3.10.2. Market Size and Forecast, By Application
        • 7.3.10.3. Market Size and Forecast, By End User

      • 7.3.11. Russia Neurosurgery Devices Market

        • 7.3.11.1. Market Size and Forecast, By Product
        • 7.3.11.2. Market Size and Forecast, By Application
        • 7.3.11.3. Market Size and Forecast, By End User

      • 7.3.12. Rest Of Europe Neurosurgery Devices Market

        • 7.3.12.1. Market Size and Forecast, By Product
        • 7.3.12.2. Market Size and Forecast, By Application
        • 7.3.12.3. Market Size and Forecast, By End User

    • 7.4. Asia-Pacific

      • 7.4.1. Key Market Trends and Opportunities

      • 7.4.2. Market Size and Forecast, By Product

      • 7.4.3. Market Size and Forecast, By Application

      • 7.4.4. Market Size and Forecast, By End User

      • 7.4.5. Market Size and Forecast, By Country

      • 7.4.6. China Neurosurgery Devices Market

        • 7.4.6.1. Market Size and Forecast, By Product
        • 7.4.6.2. Market Size and Forecast, By Application
        • 7.4.6.3. Market Size and Forecast, By End User

      • 7.4.7. Japan Neurosurgery Devices Market

        • 7.4.7.1. Market Size and Forecast, By Product
        • 7.4.7.2. Market Size and Forecast, By Application
        • 7.4.7.3. Market Size and Forecast, By End User

      • 7.4.8. India Neurosurgery Devices Market

        • 7.4.8.1. Market Size and Forecast, By Product
        • 7.4.8.2. Market Size and Forecast, By Application
        • 7.4.8.3. Market Size and Forecast, By End User

      • 7.4.9. South Korea Neurosurgery Devices Market

        • 7.4.9.1. Market Size and Forecast, By Product
        • 7.4.9.2. Market Size and Forecast, By Application
        • 7.4.9.3. Market Size and Forecast, By End User

      • 7.4.10. Australia Neurosurgery Devices Market

        • 7.4.10.1. Market Size and Forecast, By Product
        • 7.4.10.2. Market Size and Forecast, By Application
        • 7.4.10.3. Market Size and Forecast, By End User

      • 7.4.11. Thailand Neurosurgery Devices Market

        • 7.4.11.1. Market Size and Forecast, By Product
        • 7.4.11.2. Market Size and Forecast, By Application
        • 7.4.11.3. Market Size and Forecast, By End User

      • 7.4.12. Malaysia Neurosurgery Devices Market

        • 7.4.12.1. Market Size and Forecast, By Product
        • 7.4.12.2. Market Size and Forecast, By Application
        • 7.4.12.3. Market Size and Forecast, By End User

      • 7.4.13. Indonesia Neurosurgery Devices Market

        • 7.4.13.1. Market Size and Forecast, By Product
        • 7.4.13.2. Market Size and Forecast, By Application
        • 7.4.13.3. Market Size and Forecast, By End User

      • 7.4.14. Rest of Asia Pacific Neurosurgery Devices Market

        • 7.4.14.1. Market Size and Forecast, By Product
        • 7.4.14.2. Market Size and Forecast, By Application
        • 7.4.14.3. Market Size and Forecast, By End User

    • 7.5. LAMEA

      • 7.5.1. Key Market Trends and Opportunities

      • 7.5.2. Market Size and Forecast, By Product

      • 7.5.3. Market Size and Forecast, By Application

      • 7.5.4. Market Size and Forecast, By End User

      • 7.5.5. Market Size and Forecast, By Country

      • 7.5.6. Brazil Neurosurgery Devices Market

        • 7.5.6.1. Market Size and Forecast, By Product
        • 7.5.6.2. Market Size and Forecast, By Application
        • 7.5.6.3. Market Size and Forecast, By End User

      • 7.5.7. South Africa Neurosurgery Devices Market

        • 7.5.7.1. Market Size and Forecast, By Product
        • 7.5.7.2. Market Size and Forecast, By Application
        • 7.5.7.3. Market Size and Forecast, By End User

      • 7.5.8. Saudi Arabia Neurosurgery Devices Market

        • 7.5.8.1. Market Size and Forecast, By Product
        • 7.5.8.2. Market Size and Forecast, By Application
        • 7.5.8.3. Market Size and Forecast, By End User

      • 7.5.9. UAE Neurosurgery Devices Market

        • 7.5.9.1. Market Size and Forecast, By Product
        • 7.5.9.2. Market Size and Forecast, By Application
        • 7.5.9.3. Market Size and Forecast, By End User

      • 7.5.10. Argentina Neurosurgery Devices Market

        • 7.5.10.1. Market Size and Forecast, By Product
        • 7.5.10.2. Market Size and Forecast, By Application
        • 7.5.10.3. Market Size and Forecast, By End User

      • 7.5.11. Rest of LAMEA Neurosurgery Devices Market

        • 7.5.11.1. Market Size and Forecast, By Product
        • 7.5.11.2. Market Size and Forecast, By Application
        • 7.5.11.3. Market Size and Forecast, By End User

  • CHAPTER 8: COMPETITIVE LANDSCAPE

    • 8.1. Introduction

    • 8.2. Top Winning Strategies

    • 8.3. Product Mapping Of Top 10 Player

    • 8.4. Competitive Dashboard

    • 8.5. Competitive Heatmap

    • 8.6. Top Player Positioning,2022

  • CHAPTER 9: COMPANY PROFILES

    • 9.1. B Braun Melsungen

      • 9.1.1. Company Overview

      • 9.1.2. Key Executives

      • 9.1.3. Company Snapshot

      • 9.1.4. Operating Business Segments

      • 9.1.5. Product Portfolio

      • 9.1.6. Business Performance

      • 9.1.7. Key Strategic Moves and Developments

    • 9.2. Hangzhou Hawk Optical Electronic Instruments

      • 9.2.1. Company Overview

      • 9.2.2. Key Executives

      • 9.2.3. Company Snapshot

      • 9.2.4. Operating Business Segments

      • 9.2.5. Product Portfolio

      • 9.2.6. Business Performance

      • 9.2.7. Key Strategic Moves and Developments

    • 9.3. Medtronic

      • 9.3.1. Company Overview

      • 9.3.2. Key Executives

      • 9.3.3. Company Snapshot

      • 9.3.4. Operating Business Segments

      • 9.3.5. Product Portfolio

      • 9.3.6. Business Performance

      • 9.3.7. Key Strategic Moves and Developments

    • 9.4. Boston Scientific Corporation

      • 9.4.1. Company Overview

      • 9.4.2. Key Executives

      • 9.4.3. Company Snapshot

      • 9.4.4. Operating Business Segments

      • 9.4.5. Product Portfolio

      • 9.4.6. Business Performance

      • 9.4.7. Key Strategic Moves and Developments

    • 9.5. Ackermann Instrumente

      • 9.5.1. Company Overview

      • 9.5.2. Key Executives

      • 9.5.3. Company Snapshot

      • 9.5.4. Operating Business Segments

      • 9.5.5. Product Portfolio

      • 9.5.6. Business Performance

      • 9.5.7. Key Strategic Moves and Developments

    • 9.6. Nevro Corporation

      • 9.6.1. Company Overview

      • 9.6.2. Key Executives

      • 9.6.3. Company Snapshot

      • 9.6.4. Operating Business Segments

      • 9.6.5. Product Portfolio

      • 9.6.6. Business Performance

      • 9.6.7. Key Strategic Moves and Developments

    • 9.7. Adeor Medical

      • 9.7.1. Company Overview

      • 9.7.2. Key Executives

      • 9.7.3. Company Snapshot

      • 9.7.4. Operating Business Segments

      • 9.7.5. Product Portfolio

      • 9.7.6. Business Performance

      • 9.7.7. Key Strategic Moves and Developments

    • 9.8. Karl Storz

      • 9.8.1. Company Overview

      • 9.8.2. Key Executives

      • 9.8.3. Company Snapshot

      • 9.8.4. Operating Business Segments

      • 9.8.5. Product Portfolio

      • 9.8.6. Business Performance

      • 9.8.7. Key Strategic Moves and Developments

    • 9.9. Abbott

      • 9.9.1. Company Overview

      • 9.9.2. Key Executives

      • 9.9.3. Company Snapshot

      • 9.9.4. Operating Business Segments

      • 9.9.5. Product Portfolio

      • 9.9.6. Business Performance

      • 9.9.7. Key Strategic Moves and Developments

    • 9.10. Machida Endoscope Co. Ltd.

      • 9.10.1. Company Overview

      • 9.10.2. Key Executives

      • 9.10.3. Company Snapshot

      • 9.10.4. Operating Business Segments

      • 9.10.5. Product Portfolio

      • 9.10.6. Business Performance

      • 9.10.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL NEUROSURGERY DEVICES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 2. GLOBAL NEUROSURGERY DEVICES MARKET FOR NEUROSURGERY DEVICES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 3. GLOBAL NEUROSURGERY DEVICES MARKET FOR EXTERNAL NEUROSURGERY DEVICES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 4. GLOBAL NEUROSURGERY DEVICES MARKET FOR NEUROENDOSCOPY DEVICES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 5. GLOBAL NEUROSURGERY DEVICES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 6. GLOBAL NEUROSURGERY DEVICES MARKET FOR SPINAL CORD STIMULATION, BY REGION, 2022-2032 ($MILLION)
  • TABLE 7. GLOBAL NEUROSURGERY DEVICES MARKET FOR DEEP BRAIN STIMULATION, BY REGION, 2022-2032 ($MILLION)
  • TABLE 8. GLOBAL NEUROSURGERY DEVICES MARKET FOR NEURO-ENDOSCOPY, BY REGION, 2022-2032 ($MILLION)
  • TABLE 9. GLOBAL NEUROSURGERY DEVICES MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 10. GLOBAL NEUROSURGERY DEVICES MARKET FOR HOSPITALS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 11. GLOBAL NEUROSURGERY DEVICES MARKET FOR AMBULATORY SURGERY CENTER, BY REGION, 2022-2032 ($MILLION)
  • TABLE 12. GLOBAL NEUROSURGERY DEVICES MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 13. GLOBAL NEUROSURGERY DEVICES MARKET, BY REGION, 2022-2032 ($MILLION)
  • TABLE 14. NORTH AMERICA NEUROSURGERY DEVICES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 15. NORTH AMERICA NEUROSURGERY DEVICES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 16. NORTH AMERICA NEUROSURGERY DEVICES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 17. NORTH AMERICA NEUROSURGERY DEVICES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 18. U.S. NEUROSURGERY DEVICES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 19. U.S. NEUROSURGERY DEVICES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 20. U.S. NEUROSURGERY DEVICES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 21. CANADA NEUROSURGERY DEVICES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 22. CANADA NEUROSURGERY DEVICES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 23. CANADA NEUROSURGERY DEVICES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 24. MEXICO NEUROSURGERY DEVICES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 25. MEXICO NEUROSURGERY DEVICES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 26. MEXICO NEUROSURGERY DEVICES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 27. EUROPE NEUROSURGERY DEVICES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 28. EUROPE NEUROSURGERY DEVICES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 29. EUROPE NEUROSURGERY DEVICES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 30. EUROPE NEUROSURGERY DEVICES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 31. FRANCE NEUROSURGERY DEVICES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 32. FRANCE NEUROSURGERY DEVICES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 33. FRANCE NEUROSURGERY DEVICES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 34. GERMANY NEUROSURGERY DEVICES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 35. GERMANY NEUROSURGERY DEVICES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 36. GERMANY NEUROSURGERY DEVICES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 37. ITALY NEUROSURGERY DEVICES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 38. ITALY NEUROSURGERY DEVICES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 39. ITALY NEUROSURGERY DEVICES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 40. SPAIN NEUROSURGERY DEVICES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 41. SPAIN NEUROSURGERY DEVICES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 42. SPAIN NEUROSURGERY DEVICES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 43. UK NEUROSURGERY DEVICES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 44. UK NEUROSURGERY DEVICES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 45. UK NEUROSURGERY DEVICES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 46. RUSSIA NEUROSURGERY DEVICES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 47. RUSSIA NEUROSURGERY DEVICES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 48. RUSSIA NEUROSURGERY DEVICES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 49. REST OF EUROPE NEUROSURGERY DEVICES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 50. REST OF EUROPE NEUROSURGERY DEVICES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 51. REST OF EUROPE NEUROSURGERY DEVICES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 52. ASIA-PACIFIC NEUROSURGERY DEVICES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 53. ASIA-PACIFIC NEUROSURGERY DEVICES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 54. ASIA-PACIFIC NEUROSURGERY DEVICES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 55. ASIA-PACIFIC NEUROSURGERY DEVICES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 56. CHINA NEUROSURGERY DEVICES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 57. CHINA NEUROSURGERY DEVICES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 58. CHINA NEUROSURGERY DEVICES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 59. JAPAN NEUROSURGERY DEVICES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 60. JAPAN NEUROSURGERY DEVICES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 61. JAPAN NEUROSURGERY DEVICES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 62. INDIA NEUROSURGERY DEVICES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 63. INDIA NEUROSURGERY DEVICES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 64. INDIA NEUROSURGERY DEVICES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 65. SOUTH KOREA NEUROSURGERY DEVICES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 66. SOUTH KOREA NEUROSURGERY DEVICES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 67. SOUTH KOREA NEUROSURGERY DEVICES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 68. AUSTRALIA NEUROSURGERY DEVICES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 69. AUSTRALIA NEUROSURGERY DEVICES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 70. AUSTRALIA NEUROSURGERY DEVICES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 71. THAILAND NEUROSURGERY DEVICES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 72. THAILAND NEUROSURGERY DEVICES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 73. THAILAND NEUROSURGERY DEVICES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 74. MALAYSIA NEUROSURGERY DEVICES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 75. MALAYSIA NEUROSURGERY DEVICES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 76. MALAYSIA NEUROSURGERY DEVICES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 77. INDONESIA NEUROSURGERY DEVICES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 78. INDONESIA NEUROSURGERY DEVICES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 79. INDONESIA NEUROSURGERY DEVICES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 80. REST OF ASIA PACIFIC NEUROSURGERY DEVICES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 81. REST OF ASIA PACIFIC NEUROSURGERY DEVICES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 82. REST OF ASIA PACIFIC NEUROSURGERY DEVICES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 83. LAMEA NEUROSURGERY DEVICES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 84. LAMEA NEUROSURGERY DEVICES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 85. LAMEA NEUROSURGERY DEVICES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 86. LAMEA NEUROSURGERY DEVICES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 87. BRAZIL NEUROSURGERY DEVICES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 88. BRAZIL NEUROSURGERY DEVICES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 89. BRAZIL NEUROSURGERY DEVICES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 90. SOUTH AFRICA NEUROSURGERY DEVICES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 91. SOUTH AFRICA NEUROSURGERY DEVICES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 92. SOUTH AFRICA NEUROSURGERY DEVICES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 93. SAUDI ARABIA NEUROSURGERY DEVICES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 94. SAUDI ARABIA NEUROSURGERY DEVICES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 95. SAUDI ARABIA NEUROSURGERY DEVICES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 96. UAE NEUROSURGERY DEVICES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 97. UAE NEUROSURGERY DEVICES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 98. UAE NEUROSURGERY DEVICES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 99. ARGENTINA NEUROSURGERY DEVICES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 100. ARGENTINA NEUROSURGERY DEVICES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 101. ARGENTINA NEUROSURGERY DEVICES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 102. REST OF LAMEA NEUROSURGERY DEVICES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 103. REST OF LAMEA NEUROSURGERY DEVICES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 104. REST OF LAMEA NEUROSURGERY DEVICES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 105. B BRAUN MELSUNGEN: KEY EXECUTIVES
  • TABLE 106. B BRAUN MELSUNGEN: COMPANY SNAPSHOT
  • TABLE 107. B BRAUN MELSUNGEN: OPERATING SEGMENTS
  • TABLE 108. B BRAUN MELSUNGEN: PRODUCT PORTFOLIO
  • TABLE 109. B BRAUN MELSUNGEN: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 110. HANGZHOU HAWK OPTICAL ELECTRONIC INSTRUMENTS: KEY EXECUTIVES
  • TABLE 111. HANGZHOU HAWK OPTICAL ELECTRONIC INSTRUMENTS: COMPANY SNAPSHOT
  • TABLE 112. HANGZHOU HAWK OPTICAL ELECTRONIC INSTRUMENTS: OPERATING SEGMENTS
  • TABLE 113. HANGZHOU HAWK OPTICAL ELECTRONIC INSTRUMENTS: PRODUCT PORTFOLIO
  • TABLE 114. HANGZHOU HAWK OPTICAL ELECTRONIC INSTRUMENTS: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 115. MEDTRONIC: KEY EXECUTIVES
  • TABLE 116. MEDTRONIC: COMPANY SNAPSHOT
  • TABLE 117. MEDTRONIC: OPERATING SEGMENTS
  • TABLE 118. MEDTRONIC: PRODUCT PORTFOLIO
  • TABLE 119. MEDTRONIC: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 120. BOSTON SCIENTIFIC CORPORATION: KEY EXECUTIVES
  • TABLE 121. BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
  • TABLE 122. BOSTON SCIENTIFIC CORPORATION: OPERATING SEGMENTS
  • TABLE 123. BOSTON SCIENTIFIC CORPORATION: PRODUCT PORTFOLIO
  • TABLE 124. BOSTON SCIENTIFIC CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 125. ACKERMANN INSTRUMENTE: KEY EXECUTIVES
  • TABLE 126. ACKERMANN INSTRUMENTE: COMPANY SNAPSHOT
  • TABLE 127. ACKERMANN INSTRUMENTE: OPERATING SEGMENTS
  • TABLE 128. ACKERMANN INSTRUMENTE: PRODUCT PORTFOLIO
  • TABLE 129. ACKERMANN INSTRUMENTE: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 130. NEVRO CORPORATION: KEY EXECUTIVES
  • TABLE 131. NEVRO CORPORATION: COMPANY SNAPSHOT
  • TABLE 132. NEVRO CORPORATION: OPERATING SEGMENTS
  • TABLE 133. NEVRO CORPORATION: PRODUCT PORTFOLIO
  • TABLE 134. NEVRO CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 135. ADEOR MEDICAL: KEY EXECUTIVES
  • TABLE 136. ADEOR MEDICAL: COMPANY SNAPSHOT
  • TABLE 137. ADEOR MEDICAL: OPERATING SEGMENTS
  • TABLE 138. ADEOR MEDICAL: PRODUCT PORTFOLIO
  • TABLE 139. ADEOR MEDICAL: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 140. KARL STORZ: KEY EXECUTIVES
  • TABLE 141. KARL STORZ: COMPANY SNAPSHOT
  • TABLE 142. KARL STORZ: OPERATING SEGMENTS
  • TABLE 143. KARL STORZ: PRODUCT PORTFOLIO
  • TABLE 144. KARL STORZ: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 145. ABBOTT: KEY EXECUTIVES
  • TABLE 146. ABBOTT: COMPANY SNAPSHOT
  • TABLE 147. ABBOTT: OPERATING SEGMENTS
  • TABLE 148. ABBOTT: PRODUCT PORTFOLIO
  • TABLE 149. ABBOTT: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 150. MACHIDA ENDOSCOPE CO. LTD.: KEY EXECUTIVES
  • TABLE 151. MACHIDA ENDOSCOPE CO. LTD.: COMPANY SNAPSHOT
  • TABLE 152. MACHIDA ENDOSCOPE CO. LTD.: OPERATING SEGMENTS
  • TABLE 153. MACHIDA ENDOSCOPE CO. LTD.: PRODUCT PORTFOLIO
  • TABLE 154. MACHIDA ENDOSCOPE CO. LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS

  • LIST OF FIGURES

  • FIGURE 1. GLOBAL NEUROSURGERY DEVICES MARKET SEGMENTATION
  • FIGURE 2. GLOBAL NEUROSURGERY DEVICES MARKET
  • FIGURE 3. SEGMENTATION NEUROSURGERY DEVICES MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN NEUROSURGERY DEVICES MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALNEUROSURGERY DEVICES MARKET
  • FIGURE 11. NEUROSURGERY DEVICES MARKET SEGMENTATION, BY BY PRODUCT
  • FIGURE 12. NEUROSURGERY DEVICES MARKET FOR NEUROSURGERY DEVICES, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 13. NEUROSURGERY DEVICES MARKET FOR EXTERNAL NEUROSURGERY DEVICES, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 14. NEUROSURGERY DEVICES MARKET FOR NEUROENDOSCOPY DEVICES, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 15. NEUROSURGERY DEVICES MARKET SEGMENTATION, BY BY APPLICATION
  • FIGURE 16. NEUROSURGERY DEVICES MARKET FOR SPINAL CORD STIMULATION, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 17. NEUROSURGERY DEVICES MARKET FOR DEEP BRAIN STIMULATION, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 18. NEUROSURGERY DEVICES MARKET FOR NEURO-ENDOSCOPY, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 19. NEUROSURGERY DEVICES MARKET SEGMENTATION, BY BY END USER
  • FIGURE 20. NEUROSURGERY DEVICES MARKET FOR HOSPITALS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 21. NEUROSURGERY DEVICES MARKET FOR AMBULATORY SURGERY CENTER, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 22. NEUROSURGERY DEVICES MARKET FOR OTHERS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 23. TOP WINNING STRATEGIES, BY YEAR, 2020-2022*
  • FIGURE 24. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2020-2022*
  • FIGURE 25. TOP WINNING STRATEGIES, BY COMPANY, 2020-2022*
  • FIGURE 26. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 27. COMPETITIVE DASHBOARD
  • FIGURE 28. COMPETITIVE HEATMAP: NEUROSURGERY DEVICES MARKET
  • FIGURE 29. Top player positioning, 2022
  • FIGURE 30. B BRAUN MELSUNGEN: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 31. B BRAUN MELSUNGEN: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 32. B BRAUN MELSUNGEN: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 33. HANGZHOU HAWK OPTICAL ELECTRONIC INSTRUMENTS: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 34. HANGZHOU HAWK OPTICAL ELECTRONIC INSTRUMENTS: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 35. HANGZHOU HAWK OPTICAL ELECTRONIC INSTRUMENTS: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 36. MEDTRONIC: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 37. MEDTRONIC: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 38. MEDTRONIC: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 39. BOSTON SCIENTIFIC CORPORATION: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 40. BOSTON SCIENTIFIC CORPORATION: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 41. BOSTON SCIENTIFIC CORPORATION: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 42. ACKERMANN INSTRUMENTE: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 43. ACKERMANN INSTRUMENTE: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 44. ACKERMANN INSTRUMENTE: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 45. NEVRO CORPORATION: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 46. NEVRO CORPORATION: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 47. NEVRO CORPORATION: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 48. ADEOR MEDICAL: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 49. ADEOR MEDICAL: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 50. ADEOR MEDICAL: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 51. KARL STORZ: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 52. KARL STORZ: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 53. KARL STORZ: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 54. ABBOTT: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 55. ABBOTT: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 56. ABBOTT: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 57. MACHIDA ENDOSCOPE CO. LTD.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 58. MACHIDA ENDOSCOPE CO. LTD.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 59. MACHIDA ENDOSCOPE CO. LTD.: REVENUE SHARE, BY REGION, 2032 (%)

 
 
With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace


With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast


Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts


Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)


Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

PURCHASE OPTIONS

Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : +44-845-528-1300
Email : help@alliedmarketresearch.com

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Enquiry Now
RELATED TAGS

Purchase Full Report of
Neurosurgery Devices Market

Start reading.
This Report and over 66,944+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,690
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
  • Data Pack
  • $3,840
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Single User
  • $5,820
  • Restricted to one authorized user
  • One print only
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Five Users
  • $6,540
  • Limited to five authorized users
  • Print upto five copies
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle

  • Enterprise
    License/PDF

  • $9,870
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle

  • Library
    Membership

  • $999 $ 1,175
    Per User/ Per month/ Billed annually
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

RELATED REPORTS
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers